Provided by Tiger Trade Technology Pte. Ltd.

Kalvista Pharmaceuticals Inc

19.33
+0.38002.01%
Post-market: 19.330.00000.00%19:50 EDT
Volume:2.06M
Turnover:39.99M
Market Cap:990.13M
PE:-6.34
High:19.95
Open:19.14
Low:18.82
Close:18.95
52wk High:19.95
52wk Low:9.24
Shares:51.22M
Float Shares:27.92M
Volume Ratio:1.51
T/O Rate:7.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0497
EPS(LYR):-3.0497
ROE:-190.18%
ROA:-60.98%
PB:-365.23
PE(LYR):-6.34

Loading ...

Kalvista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025

THOMSON REUTERS
·
Nov 03, 2025

KalVista price target lowered to $29 from $36 at BofA

TIPRANKS
·
Oct 22, 2025

BofA Securities Adjusts KalVista Pharmaceuticals Price Target to $29 From $36, Maintains Buy Rating

MT Newswires Live
·
Oct 22, 2025

Kalvista Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $29 From $36

THOMSON REUTERS
·
Oct 22, 2025

KalVista Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Operations Officer Arif Bilal

Reuters
·
Oct 09, 2025

KalVista Pharmaceuticals Announces Positive Clinical Data and European Launch of EKTERLY®, the First Oral On-Demand Treatment for Hereditary Angioedema

Reuters
·
Oct 07, 2025

KalVista Pharmaceuticals Appoints Bilal Arif as COO and Linea Aspesi as Chief People Officer Amid Global EKTERLY Launch

Reuters
·
Oct 06, 2025

Kalvista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer

THOMSON REUTERS
·
Oct 06, 2025

KalVista Pharmaceuticals Grants Stock Options to New Employees Under Inducement Equity Incentive Plan

Reuters
·
Oct 03, 2025

KalVista Pharmaceuticals Appoints Bethany L. Sensenig to Board of Directors and Audit Committee

Reuters
·
Oct 02, 2025

Kalvista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors

THOMSON REUTERS
·
Oct 02, 2025

H.C. Wainwright Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)

TIPRANKS
·
Oct 01, 2025

KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, with Option for Additional $15 Million

Reuters
·
Sep 30, 2025